Producing LEU-based Mo-99 to reduce the use of HEU Belgium’s Institute for Radioelements (IRE) announced that the company produced its first commercial Molybdenum-99 Low Enriched Uranium (LEU) batch for the US market. This conversion to LEU represents a key milestone for IRE in the global efforts to end the civil use of High Enriched Uranium…
TUM and Framatome to develop UMo fuel for nuclear research reactor Framatome and the Technical University of Munich (TUM) recently started the commercial development of uranium-molybdenum fuel (UMo) for nuclear research reactors. Framatome and TUM will design and install a fuel manufacturing production line, developing, producing and irradiating new fuel prototypes. The project will take…
Reactor Petten record production of medical isotopes Last month, the reactor in Petten had a record production and was therefore able to continue to provide 30,000 patients daily with medical isotopes. The Corona crisis has caused complications for transport and logistics and due to this the European manufacturers are now turning to NRG. Jojanneke van…
Medical Isotopes – International Experts Call For Action To Secure Supply International experts from irradiating reactors, other isotope producers, and direct users urgently call for a long-term strategy to prevent a critical shortage of research and production capacities. They jointly ask for a common framework that stimulates much needed policy changes and investments. The high-level…
Actinium-225, The Joint-Venture Pantera To Secure Its Production The Belgian Nuclear Research Centre SCK CEN (ENS Corporate Member) and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announced last week the name of their joint-venture: Pantera SA/NV, resulting from strategic R&D partnership between SCK CEN and IBA to enable the production…
Commercial Production Of Lutetium-177 Starts At Bruce NPP The international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company) and ITM Isotope Technologies Munich SE (ITM) announced today the start of commercial production of lutetium-177. It marks the first-of-its-kind achievement of a commercial power reactor with additional capability to commercially produce short-lived medical isotopes.…
Mo-99 Ready To Be Produced At Darlington NPP The Darlington Nuclear Power Plant, located in Canada and operated by Ontario Power Generation (OPG), is now ready to produce life-saving Molybdenum-99 (Mo-99) isotopes, Laurentis Energy Partners and BWXT Medical Ltd announced last week. Thanks to the installation and initial commissioning of an innovative isotope system made…
NRG And TerThera Cooperate To Secure Terbium-161 Supply Last week, NRG (ENS Corporate Member) and TerThera signed an agreement for irradiation services in the High Flux Reactor in Petten to produce Terbium-161. The non-carrier-added (NCA) Terbium-161 is produced by neutron irradiation of highly enriched Gadolinium-160 targets in the Dutch research reactor. Terbium-161 is a promising novel…
SCK CEN And TerThera Collaborate To Secure Terbium-161 Supply SCK CEN (ENS Corporate Member) and TerThera signed an agreement to handle together the production process of Terbium-161, a promising novel radionuclide for cancer treatment. Terbium-161 can meet the growing demand in cancer healthcare, exhibiting comparable (radio)chemical characteristics to known radiolanthanides. Targeted cancer therapies with Terbium-161 are expected…
Full Financing For PALLAS Reactor Announced By Dutch Minister The Dutch Minister of Health, Welfare and Sport Ernst Kuipers announced yesterday that there is full financing for the construction of the PALLAS reactor. This is a major step towards realising the new facility in Petten, North Holland. The construction of a new reactor would be…